(HealthDay)—Methodological concerns have limited the analysis of saliva-based biomarkers for oral squamous cell carcinoma (OSCC), according to a review published online Nov. 29 in Head and Neck.
Dec 5, 2016
0
0
Grafting sheets of a patient's genetically corrected skin to open wounds caused by the blistering skin disease epidermolysis bullosa appears to be well-tolerated and improves wound healing, according to a phase-1 clinical ...
Nov 1, 2016
0
128
The rise in incidence of oropharyngeal squamous cell carcinoma in the United Kingdom from 2002 to 2011 was not solely attributable to a rise in incidence of human papillomavirus (HPV)-positive disease because the proportion ...
Oct 11, 2016
0
0
In the first study of its kind researchers from the University of Liverpool's Institute of Translational Medicine have examined the possible reasons for the rapid increase in incidence of particular head and neck cancers ...
Oct 10, 2016
0
0
When she was just 12, Julie Breneiser had her first skin cancer removed and three large tumors carved out of her jawbone. Since then she has undergone surgeries for two more jaw growths and many, many more basal cell carcinomas—"hundreds, ...
Oct 5, 2016
0
0
(HealthDay)—Use of nonsurgical therapy is increasing for advanced-stage oral cavity squamous cell carcinoma (SCC), although survival is better with surgical therapy, according to a study published online Sept. 19 in Head ...
Sep 29, 2016
0
0
(HealthDay)—For patients with clinically node-negative oral cavity squamous cell carcinoma, the addition of elective neck dissection to primary surgery is associated with a reduction in overall costs, according to a study ...
Aug 23, 2016
0
0
Afatinib (trade name: Giotrif) has been approved since April 2016 for the treatment of adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) of squamous histology who have already received chemotherapy. ...
Aug 18, 2016
0
1
Computers can be trained to be more accurate than pathologists in assessing slides of lung cancer tissues, according to a new study by researchers at the Stanford University School of Medicine.
Aug 16, 2016
0
83
(HealthDay)—Life expectancy does not appear to influence patterns of treatment for keratinocyte carcinoma (KC), according to a study published online June 15 in the Journal of the American Geriatrics Society.
Jun 20, 2016
0
0
